Phase 1 Study of Bortezomib, Fludarabine, and Melphalan, With or Without Total Marrow Irradiation, as Allogeneic Hematopoietic Stem Cell Transplant Conditioning for High-risk or Relapsed/Refractory Multiple Myeloma.
Colton LadburyJames SanchezArnab ChowdhuryJoycelynne PalmerAn LiuAnthony SteinMyo HtutLeonardo FarolJi-Lian CaiGeorge SomloMichael RosenzweigJeffrey C WongFiroozeh SahebiPublished in: American journal of clinical oncology (2024)
TMI 900 cGy, FLU, and MEL are considered feasible as conditioning for allogeneic stem cell transplantation and may warrant further investigation due to favorable response rates and survival.